The Tri-Institutional MD-PhD Program (Tri-I), a Medical Scientist Training Program (MSTP), is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

On October 19, 2020 the National Academy of Medicine announced the election of its new members for this year. Included among the 90 distinguished doctors are two Tri-Institutional MD-PhD alumni, Wendy K. Chung, M.D., PhD (Tri-I graduating class of 1998) and David E. Fisher, PhD, MD  (Tri-I graduating class of 1985).
Dr. Clark Fisher, MD, PhD, (Tri-I MD-PhD graduating class of 2017), currently at Yale University, has developed a ventilator circuit that can support two patients with individualized peak inspiratory and end-expiratory pressures. Dr. Fisher's project addresses the current shortage of ICU ventilators experienced by hospitals across the United States and the world with a a low-cost, off the shelf solution to stretch the limited resources available.